ValiRx PLC
LSE:VAL

Watchlist Manager
ValiRx PLC Logo
ValiRx PLC
LSE:VAL
Watchlist
Price: 0.476 GBX 13.33%
Market Cap: 3.5m GBX

Net Margin
ValiRx PLC

-3 580.7%
Current
-7 030%
Average
-6.6%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-3 580.7%
=
Net Income
-1.8m
/
Revenue
49.8k

Net Margin Across Competitors

No Stocks Found

ValiRx PLC
Glance View

Market Cap
3.5m GBX
Industry
Biotechnology

ValiRx Plc is a life science company, which focuses on clinical stage cancer therapeutic development, taking proprietary and novel technology for precision medicines towards commercialization and partnering. The company is headquartered in Nuneaton, Warwickshire and currently employs 10 full-time employees. The company went IPO on 2000-02-28. The firm is engaged in the development of oncology therapeutics and companion diagnostics. The company focuses on the development of treatments in cancer and women’s health. Its product pipeline includes VAL201, VAL301, VAL401 and BC201. Its VAL201 is an anti-cancer therapeutic drug, which is in clinical trials for the treatment of prostate cancer. Its VAL301 for the treatment of women with endometriosis. Its VAL401 is the reformulation of a generic drug for treatment of a chronic non-oncology disease in an oral capsule. Its BC201 is a combination of the peptide ingredient of VAL201 with active components to dampen this excessive immune response and consequently improve severe symptoms of Covid-19. The company operates through divisional companies, including ValiPharma and ValiSeek.

VAL Intrinsic Value
0.077 GBX
Overvaluation 84%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-3 580.7%
=
Net Income
-1.8m
/
Revenue
49.8k
What is the Net Margin of ValiRx PLC?

Based on ValiRx PLC's most recent financial statements, the company has Net Margin of -3 580.7%.

Back to Top